oncolytic - International Biopharmaceutical Industry

Current Edition

Volume 4 Issue 3

How to Bring Your Oncolytic Virus Innovation to Market: the Secret to Successful Development

Cancer continues to be a major burden on healthcare systems across the world, with global spending on therapies and supportive care drugs expected to reach $200 billi...

1 September 2021 Volume 4 Issue 3 development | innovation

Continue Reading →

news

Vyriad signs a contract with IBM to build an oncolytic virus anti-cancer vaccines manufacturing facility

The custom buildout will be financed with proceeds from a recently completed $9 million secured convertible note financing, which included participation by Mayo Clini...

14 May 2018 news build | contract

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

How to Bring Your Oncolytic Virus Innovation to Market: the Secret to Successful Development

Vyriad signs a contract with IBM to build an oncolytic virus anti-cancer vaccines manufacturing facility

International Biopharmaceutical Industry